Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03575819 |
| Title | A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) |
| Recruitment | Completed |
| Gender | male |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Fortis Therapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| UCLA Institute of Urologic Oncology | Los Angeles | California | 90095 | United States | Details | |
| UCSF Helen Diller Family Comprehensive Cancer Center | San Francisco | California | 94143 | United States | Details | |
| Northwestern University | Chicago | Illinois | 60611 | United States | Details | |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | United States | Details | |
| OHSU Knight Cancer Institute | Portland | Oregon | 06903 | United States | Details |